Teneligliptin (INN; trade name Tenelia) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins".[1]
Clinical data | |
---|---|
Trade names | Tenelia |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H30N6OS |
Molar mass | 426.58 g·mol−1 |
3D model (JSmol) | |
| |
|
Creation
editIt was created by Mitsubishi Tanabe Pharma and launched in September 2012 by both Mitsubishi Tanabe Pharma and Daiichi Sankyo in Japan.[2]
Licensing and use
editJapan/Korea/India/Argentina
editIt is approved for use in Japan, Argentina, Korea and India.[3]
Pharmacology
editTeneligliptin has unique J-shaped or anchor locked domain structure because of which it has a potent inhibition of DPP 4 enzyme.
Teneligliptin significantly controls glycemic parameters with safety. No dose adjustment is required in renally impaired patients.[4]
References
edit- ^ Kishimoto M (2013). "Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes". Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 6: 187–195. doi:10.2147/DMSO.S35682. PMC 3650886. PMID 23671395.
- ^ "TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Approval of Partial Change in Indication to Lift Restrictions in Combination Therapy". Media & Investors. Daiichi Sankyo. 20 December 2013. Archived from the original on 24 November 2015.
- ^ Bronson J, Black A, Dhar TG, Ellsworth BA, Merritt JR (2013). "Teneligliptin (Antidiabetic), Chapter: To Market, To Market - 2012". Annual Reports in Medicinal Chemistry. Vol. 48. pp. 523–524. doi:10.1016/b978-0-12-417150-3.00028-4. ISBN 978-0-12-417150-3.
- ^ Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, Kadowaki T (May 2013). "A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site". Biochemical and Biophysical Research Communications. 434 (2): 191–196. doi:10.1016/j.bbrc.2013.03.010. PMID 23501107.
🔥 Top keywords: Akademia e Shkencave e RPS te ShqiperiseAlexandria Ocasio-CortezBilderberg GroupCristiano RonaldoDong XiaowanMinecraftOperation GladioPrimal cutRiot FestStrictly Come Dancing (series 7)Main PageSpecial:SearchWikipedia:Featured picturesUEFA Euro 2024Derek JeterJamal MusialaBridgertonInside Out 2UEFA European Championship2024 ICC Men's T20 World CupCleopatraThe Boys (TV series)The Boys season 4Deaths in 2024Pawan KalyanNATO phonetic alphabetUEFA Euro 2020ChatGPTG7Giorgia Meloni.xxxYouTubeNicola CoughlanGermany national football teamBiggest ball of twineOpinion polling for the 2024 United Kingdom general electionJuneteenthJerry WestFlag Day (United States)Project 2025Scotland national football teamJulian NagelsmannDutch rollAndrew McCarthyDonald TrumpThe Acolyte (TV series)ICC Men's T20 World CupFlorian WirtzHit Man (2023 film)